Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
British American Tobacco has delivered a very strong 5 year share price gain, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) still suggest the stock trades at a discount to what its cash flows imply.
The share price is up about 126.7% over 5 years, which puts recent short term weakness into context for anyone judging the current entry point.
The expanded multi year technology partnership with ITC Infotech can support efficiency and cash flow over time. However, any setback in execution or regulatory pressure may weigh on how much of that value investors are willing to price in.
British American Tobacco screens as undervalued on 5 out of 6 checks, and this high value score supports the view that the broader metrics lean cheap.
The issue now is whether British American Tobacco’s current share price at around £42.14 still leaves enough of a discount to its intrinsic value to appeal to valuation driven investors.
Does British American Tobacco Look Undervalued on Cash Flow?
The Discounted Cash Flow model values British American Tobacco by projecting its future free cash flows and discounting them back to today. The latest twelve month free cash flow sits at about £6.8b, and the projections used in this model assume those cash flows grow rather than contract over time.
On these assumptions, the intrinsic value comes out at about £82.72 per share, compared with a current share price near £42.14. That gap implies the stock screens as roughly 49.1% undervalued on this DCF view. The recently expanded multi year technology partnership with ITC Infotech may help explain why the model builds in ongoing cash generation, even though the market is still pricing British American Tobacco materially below the cash flow estimate.
Overall, the Discounted Cash Flow work suggests British American Tobacco appears undervalued at current levels.
Our Discounted Cash Flow (DCF) analysis suggests British American Tobacco is undervalued by 49.1%. Track this in your watchlist or portfolio, or discover 10 more high quality undervalued stocks.
BATS Discounted Cash Flow as at Aug 2026
Is British American Tobacco Still Cheap on Earnings?
Story Continues
P/E can be a useful cross-check for British American Tobacco because earnings remain a key focus for many investors in established tobacco businesses. On this measure, the stock trades on a P/E of about 14.3x, compared with an industry average near 11.9x and a peer group average around 18.9x.
The fair P/E ratio implied by the model is about 24.8x. That is above the current 14.3x, which indicates that the market price may not fully reflect the earnings profile that the model assumes for British American Tobacco, even though it already trades at a premium to the broader tobacco sector average.
On the P/E multiple, British American Tobacco stock appears undervalued relative to the earnings level implied by the fair ratio.
LSE:BATS P/E Ratio as at Aug 2026
See what the numbers say about this price — find out in our valuation breakdown.
The British American Tobacco Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives help you see what kind of future would need to play out for British American Tobacco’s current valuation puzzle to close in either direction by making clear which assumptions on growth, margins and earnings would have to hold for the stock to be worth materially more or less than today’s price on the Community page. Where a single ratio or model gives one headline figure, these narratives unpack the future behind that number so you can track whether it still fits as new information emerges.
The community is split on British American Tobacco, with one camp focused on the smokeless transition and another zeroed in on long term legal and regulatory risk.
Bull case: 16% undervalued
“Digital transformation, operational streamlining, and targeted cost savings programs (e.g., Fit2Win, global supply chain efficiencies) are releasing capital for reinvestment in high-return growth opportunities and innovation…”
Read the full Bull Case to see why British American Tobacco could be undervalued
Bear case: 7% overvalued
“Accelerating global regulation and legislative restrictions on both combustible and next-generation tobacco products are expected to further limit BAT’s ability to grow volumes and raise prices…”
Read the full Bear Case to see why British American Tobacco could be overvalued
Do you think there’s more to the story for British American Tobacco? Head over to our Community to see what others are saying!
The Bottom Line
British American Tobacco still screens as undervalued on both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiple work. The key question is whether cash flows and margins hold up well enough for that intrinsic value case to stay intact while the market remains cautious on regulation and the smokeless transition. For you, the crux is whether this discount reflects genuine mispricing or is a fair penalty for long term legal and regulatory risk that could limit how much of that intrinsic value is ever realised.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BATS.L.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com